vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $240.5M, roughly 1.1× COGENT COMMUNICATIONS HOLDINGS, INC.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -12.8%, a 14.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -4.7%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -4.9%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Cogent Communications Holdings, Inc. is a multinational internet service provider based in the United States. Cogent's primary services consist of Internet access and data transport, offered on a fiber optic, IP data-only network, along with colocation in data centers.

ACAD vs CCOI — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.1× larger
ACAD
$268.1M
$240.5M
CCOI
Growing faster (revenue YoY)
ACAD
ACAD
+14.4% gap
ACAD
9.7%
-4.7%
CCOI
Higher net margin
ACAD
ACAD
14.2% more per $
ACAD
1.4%
-12.8%
CCOI
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
5.3%
-4.9%
CCOI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACAD
ACAD
CCOI
CCOI
Revenue
$268.1M
$240.5M
Net Profit
$3.6M
$-30.8M
Gross Margin
46.6%
Operating Margin
-1.7%
-4.7%
Net Margin
1.4%
-12.8%
Revenue YoY
9.7%
-4.7%
Net Profit YoY
28.9%
EPS (diluted)
$0.02
$-0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
CCOI
CCOI
Q1 26
$268.1M
Q4 25
$284.0M
$240.5M
Q3 25
$278.6M
$241.9M
Q2 25
$264.6M
$246.2M
Q1 25
$244.3M
$247.0M
Q4 24
$259.6M
$252.3M
Q3 24
$250.4M
$257.2M
Q2 24
$242.0M
$260.4M
Net Profit
ACAD
ACAD
CCOI
CCOI
Q1 26
$3.6M
Q4 25
$273.6M
$-30.8M
Q3 25
$71.8M
$-41.5M
Q2 25
$26.7M
$-57.8M
Q1 25
$19.0M
$-52.0M
Q4 24
$143.7M
$-43.3M
Q3 24
$32.8M
$-63.1M
Q2 24
$33.4M
$-32.3M
Gross Margin
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
90.8%
46.6%
Q3 25
92.2%
45.6%
Q2 25
92.2%
44.2%
Q1 25
91.7%
44.4%
Q4 24
91.6%
38.5%
Q3 24
92.5%
37.2%
Q2 24
92.5%
40.0%
Operating Margin
ACAD
ACAD
CCOI
CCOI
Q1 26
-1.7%
Q4 25
6.1%
-4.7%
Q3 25
12.8%
-7.5%
Q2 25
12.2%
-12.8%
Q1 25
7.9%
-16.3%
Q4 24
59.1%
-13.2%
Q3 24
12.6%
-22.5%
Q2 24
12.6%
-18.1%
Net Margin
ACAD
ACAD
CCOI
CCOI
Q1 26
1.4%
Q4 25
96.3%
-12.8%
Q3 25
25.8%
-17.2%
Q2 25
10.1%
-23.5%
Q1 25
7.8%
-21.1%
Q4 24
55.4%
-17.2%
Q3 24
13.1%
-24.5%
Q2 24
13.8%
-12.4%
EPS (diluted)
ACAD
ACAD
CCOI
CCOI
Q1 26
$0.02
Q4 25
$1.61
$-0.63
Q3 25
$0.42
$-0.87
Q2 25
$0.16
$-1.21
Q1 25
$0.11
$-1.09
Q4 24
$0.86
$-0.89
Q3 24
$0.20
$-1.33
Q2 24
$0.20
$-0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
CCOI
CCOI
Cash + ST InvestmentsLiquidity on hand
$148.5M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$-63.8M
Total Assets
$1.6B
$3.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
$177.7M
$148.5M
Q3 25
$258.0M
$147.1M
Q2 25
$253.6M
$213.7M
Q1 25
$217.7M
$153.8M
Q4 24
$319.6M
$198.5M
Q3 24
$155.1M
$279.2M
Q2 24
$177.1M
$384.4M
Total Debt
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
$1.7B
Q3 25
Q2 25
Q1 25
Q4 24
$1.5B
Q3 24
Q2 24
Stockholders' Equity
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
$1.2B
$-63.8M
Q3 25
$917.3M
$-39.2M
Q2 25
$822.4M
$46.7M
Q1 25
$765.2M
$142.8M
Q4 24
$732.8M
$222.8M
Q3 24
$577.2M
$323.6M
Q2 24
$516.7M
$415.5M
Total Assets
ACAD
ACAD
CCOI
CCOI
Q1 26
$1.6B
Q4 25
$1.6B
$3.1B
Q3 25
$1.3B
$3.1B
Q2 25
$1.2B
$3.3B
Q1 25
$1.1B
$3.1B
Q4 24
$1.2B
$3.2B
Q3 24
$976.9M
$3.2B
Q2 24
$914.1M
$3.3B
Debt / Equity
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
6.53×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
CCOI
CCOI
Operating Cash FlowLast quarter
$-6.0M
Free Cash FlowOCF − Capex
$-43.0M
FCF MarginFCF / Revenue
-17.9%
Capex IntensityCapex / Revenue
15.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-198.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
$-48.7M
$-6.0M
Q3 25
$74.3M
$3.1M
Q2 25
$64.0M
$-44.0M
Q1 25
$20.3M
$36.4M
Q4 24
$40.4M
$14.5M
Q3 24
$63.2M
$-20.2M
Q2 24
$25.0M
$-22.2M
Free Cash Flow
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
$-43.0M
Q3 25
$73.9M
$-33.1M
Q2 25
$-100.2M
Q1 25
$-21.7M
Q4 24
$-31.6M
Q3 24
$63.2M
$-79.5M
Q2 24
$-70.9M
FCF Margin
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
-17.9%
Q3 25
26.5%
-13.7%
Q2 25
-40.7%
Q1 25
-8.8%
Q4 24
-12.5%
Q3 24
25.2%
-30.9%
Q2 24
-27.2%
Capex Intensity
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
15.4%
Q3 25
0.1%
15.0%
Q2 25
22.8%
Q1 25
23.5%
Q4 24
18.3%
Q3 24
0.0%
23.0%
Q2 24
18.7%
Cash Conversion
ACAD
ACAD
CCOI
CCOI
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons